2023
|
Invention
|
Treatment of constipation-predominant irritable bowel syndrome.
The invention provides methods f... |
|
Invention
|
Low-dose stable formulations of linaclotide.
The present invention relates to stable pharmaceuti... |
|
Invention
|
Delayed release compositions of linaclotide.
The present invention relates to delayed release ph... |
|
Invention
|
Stable formulations of linaclotide.
The present invention relates to stable pharmaceutical compo... |
|
Invention
|
Stable solid formulation of gc-c receptor agonist polypeptide suitable for oral administration.
... |
2021
|
Invention
|
Stable solid formulation of a gc-c receptor agonist polypeptide suitable for oral administration.... |
2020
|
Invention
|
Modified release formulations of memantine oral dosage forms.
The present invention provides pha... |
|
Invention
|
Stable dosage forms of levomilnacipran.
The present invention relates to stable dosage forms of ... |
2019
|
Invention
|
Linaclotide compositions.
The present invention is directed to stable linaclotide compositions a... |
2018
|
Invention
|
Nmda receptor modulators and uses thereof.
Disclosed are compounds having enhanced potency in th... |
2017
|
Invention
|
Donepezil compositions and methods of treating alzheimers disease.
Oral dosage forms comprising ... |
|
Invention
|
Compositions and methods for treating bacterial infections using ceftaroline.
The present invent... |
|
Invention
|
Orally dissolving formulations of memantine.
Orally dissolving formulations, e.g., tablets (ODTs... |
|
Invention
|
Novel crystalline forms of trans-7-oxo-6-(sulphooxy)-1,6-diazabicyclo[3,2,1]octane-2-carboxamide ... |
2016
|
Invention
|
Modified and immediate release formulations of memantine.
The present invention provides immedia... |
|
Invention
|
Modified release formulations of memantine oral dosage forms. The present invention provides phar... |
2015
|
Invention
|
Crystalline forms of trans-7-oxo-6-(sulphooxy)-1,6-diazabicyclo[3,2,1]octane-2-carboxamide sodium... |
|
Invention
|
Soluble dosage forms containing cephem derivatives suitable for parenteral administration.
The p... |
|
Invention
|
Roflumilast compositions for the treatment of copd.
The present invention relates to pharmaceuti... |
|
Invention
|
Donepezil compositions and method of treating alzheimer's disease. Oral dosage forms comprising d... |
|
Invention
|
Donepezil compositions and methods of treating alzheimer's disease. Oral dosage forms comprising ... |
2014
|
Invention
|
Delayed release compositions of linaclotide. The present invention relates to delayed release pha... |
|
Invention
|
Pharmaceutical formulations comprising vilazodone. The present invention provides an immediate re... |
|
Invention
|
Combination therapy for the treatment of nosocomial pneumonia.
The present invention relates to ... |